42 results on '"Kiyomi, Fumiaki"'
Search Results
2. A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study
3. A protocol of a single arm, prospective, open-label, multicenter, phase II study of ramucirumab and erlotinib in treatment-naïve non-small cell lung cancer patients with EGFR mutation and brain metastases (SPIRAL-BRAIN study)
4. Comparison of the cytokine adsorption ability in continuous renal replacement therapy using polyethyleneimine-coated polyacrylonitrile (AN69ST) or polymethylmethacrylate (PMMA) hemofilters: a pilot single-center open-label randomized control trial
5. Prophylactic treatment of dacomitinib‐induced skin toxicities in epidermal growth factor receptor‐mutated non–small‐cell lung cancer: A multicenter, Phase II trial
6. Evaluation of the safety and effectiveness of cryoablation in the treatment of renal angiomyolipoma related to tuberous sclerosis complex: The Cryo-TSC.
7. Comparison of the cytokine adsorption ability in continuous renal replacement therapy using polyethyleneimine-coated or polymethylmethacrylate hemofilters: a pilot single-center open-label randomized control trial
8. Estimating colorectal polyp size with a virtual scale endoscope and visual estimation during colonoscopy: Prospective, preliminary comparison of accuracy
9. Comprehensive geriatric assessment as a useful tool in predicting adverse events in elderly patients with diffuse large B-cell lymphoma
10. Evaluation of safety and effectiveness of cryoablation in the treatment of renal angiomyolipoma related to tuberous sclerosis complex: The Cryo-TSC study.
11. Phase II Study of Nivolumab Plus Ipilimumab with Platinum-Based Chemotherapy for Treatment-Naïve Advanced Non-Small Cell Lung Cancer with Untreated Brain Metastases: NIke Trial (LOGiK2004)
12. 5-Nitrouracil stabilizes the plasma concentration values of 5-FU in colorectal cancer patients receiving capecitabine
13. Rationale and design of a phase II trial of durvalumab treatment in patients with NSCLC ineligible for stage III chemoradiotherapy following radiation monotherapy (SPIRAL-RT study)
14. Rationale and design of a phase II study to evaluate prophylactic treatment of dacomitinib-induced dermatologic adverse events in epidermal growth factor receptor-mutated advanced non-small cell lung cancer (SPIRAL-Daco study)
15. Criteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis: A proposal
16. Assessment of inter-rater agreement between physicians and their patients regarding medication adherence in a clinical questionnaire study
17. Comparison of accuracy of presepsin and procalcitonin concentrations in diagnosing sepsis in patients with and without acute kidney injury
18. Evaluation of vascular pain in patients with colorectal cancer receiving peripheral venous chemotherapy with or without oxaliplatin
19. Bacterial contamination upon the opening of injection needles
20. Poorly Differentiated Clusters Predict a Poor Prognosis for External Auditory Canal Carcinoma
21. Phase II study on early start of chemotherapy after excising primary colorectal cancer with distant metastases (Pearl Star 02)
22. C-MYC and Its Main Ubiquitin Ligase, FBXW7, Influence Cell Proliferation and Prognosis in Adult T-cell Leukemia/Lymphoma
23. Nε-(carboxymethyl)lysine Concentration in Debris from Carotid Artery Stenting Correlates Independently with Signal Intensity on T1-Weighted Black-Blood Magnetic Resonance Images
24. Fibrinogen level on admission is a predictor for massive transfusion in patients with severe blunt trauma: Analyses of a retrospective multicentre observational study
25. Increased biofilm formation ability and accelerated transport of Staphylococcus aureus along a catheter during reciprocal movements
26. Relationship between the Carotid Plaque T1 Relaxation Time and the Plaque-to-Muscle Signal Intensity Ratio on Black-Blood Magnetic Resonance Imaging Scans
27. Objective evaluation of oxaliplatin-induced vascular pain secondary to peripheral vein administration
28. Heterogeneous clinical features in patients with pulmonary fibrosis showing histology of pleuroparenchymal fibroelastosis
29. Comparison of intra-individual coefficients of variation on the paired sampling data when inter-individual variations are different between measures
30. Methods of Providing Valid Information for Improvement of Recruitment Based on an Analysis of Voluntary Clinical Trial Participants in a University Hospital
31. Retrospective Analysis of Treatment Outcomes and Geriatric Assessment in Elderly Malignant Lymphoma Patients
32. 1056
33. Subjective and objective assessment of oxaliplatin-induced peripheral neuropathy
34. A single-arm Phase II validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone: the AVOID trial
35. Subjective and objective assessment of oxaliplatin-induced peripheral neuropathy
36. Subjective and objective assessment of oxaliplatin-induced peripheral neuropathy.
37. The difference between the subjective and objective evaluation of oxaliplatin-induced vascular pain due to administer chemotherapy via peripheral vein.
38. The Impact of Long-Term Growth Hormone Treatment on Metabolic Parameters in Japanese Patients with Short Stature Born Small for Gestational Age
39. Some Notes on Adjustment for Covariates
40. Multivariate Structural Analysis of Agreement for Categorical Data
41. Considerations on Analysis of Covariance with a Baseline Covariate: Application in Randomized Clinical Trials
42. A Generalized Play-The-Winner Sampling with Inverse Stopping Rules
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.